WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
This Quarter Return
-22.85%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$825M
AUM Growth
+$825M
(-27%)
Cap. Flow
+$84.4M
Cap. Flow
% of AUM
10.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
4
Increased
4
Reduced
1
Closed
–
Top Buys
| 1 |
AUTL
Autolus Therapeutics
AUTL
|
$42.6M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$32.8M |
| 3 |
Theravance Biopharma
TBPH
|
$7.14M |
| 4 |
Altria Group
MO
|
$6.7M |
| 5 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
$5.77M |
Top Sells
| 1 |
Alkermes
ALKS
|
$22.8M |
Sector Composition
| 1 | Healthcare | 99.19% |
| 2 | Consumer Staples | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Theravance Biopharma
TBPH
$699M
| $254M | 30.84% | 11,213,879 +315,000 | +3% | +$7.14M |
|
|
2
Alkermes
ALKS
$4.78B
| $194M | 23.54% | 4,717,010 -553,418 | -11% | -$22.8M |
|
3
Prothena Corp
PRTA
$441M
| $174M | 21.08% | 11,924,614 +367,000 | +3% | +$5.35M |
|
4
Biogen
BIIB
$19.4B
| $81.1M | 9.84% | 279,564 | – | – |
|
|
AUTL
5
Autolus Therapeutics
AUTL
$399M
| $42.6M | 5.17% | +1,591,743 | New | +$42.6M |
|
|
6
Agios Pharmaceuticals
AGIO
$2.19B
| $32.8M | 3.98% | +390,000 | New | +$32.8M |
|
|
EVFM
7
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $26M | 3.15% | 9,593,197 +2,127,659 | +28% | +$5.77M |
|
|
NCNA
8
NuCana
NCNA
$6.09M
| $7.98M | 0.97% | 420,000 +90,000 | +27% | +$1.71M |
|
|
9
Altria Group
MO
$113B
| $6.7M | 0.81% | +118,000 | New | +$6.7M |
|
|
NITE
10
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $5.02M | 0.61% | +314,000 | New | +$5.02M |
|